Randomized phase II study of cisplatin and etoposide versus temozolomide and capecitabine in patients (pts) with advanced G3 non-small cell gastroenteropancreatic neuroendocrine carcinomas (GEPNEC): A trial of the ECOG-ACRIN Cancer Research Group (EA2142) Meeting Abstract
| Authors: | Eads, J. R.; Catalano, P. J.; Fisher, G. A.; Klimstra, D. S.; Zhang, Z.; Rubin, D.; Iagaru, A.; Wong, T. Z.; O'Dwyer, P. J. |
| Abstract Title: | Randomized phase II study of cisplatin and etoposide versus temozolomide and capecitabine in patients (pts) with advanced G3 non-small cell gastroenteropancreatic neuroendocrine carcinomas (GEPNEC): A trial of the ECOG-ACRIN Cancer Research Group (EA2142) |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Start Page: | 242s |
| Language: | English |
| ACCESSION: | WOS:000404665406113 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.TPS4149 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS4149 -- Source: Wos |
